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AMINO ACID CONTENT OF BLOOD AND URINE IN PSORIASIS*
RICHARD W. HUBBARD, Pn.D., BETTY F. STEELE, Pn.D., VICTOR SPEAR, M.D. AND
WALTER D. BLOCK, PH.D.
Many biochemical constituents of blood and
urine from psoriatic and non-psoriatic individuals
have been studied with the purpose of detecting
a metabolic difference between the two (1—8).
Results of these investigations have been equi-
vocal with no indication of the existence of a
major biochemical difference.
In individuals with psoriasis the rapid forma-
tion of hyperkeratotie and parakeratotie scales
containing protein or protein-like substances,
may indicate that amino acids are required for
the synthesis of theèe substances in amounts
qualitatively or quantitatively different from
those of non-psoriatic individuals. If such differ-
ences exist, they may be reflected in the pattern
of amino acids in blood and urine. Urinary and
plasma amino acids were determined in a series
of patients with psoriasis by use of quantitative
ion-exchange chromatography, and the results
compared with those for control subjects.
FR0cEmJRES
Subjects. Thirteen psoriatie patients, 5 females
and 8 males, ranging in age from 13 to 65 years
were studied. Duration of the psoriasis ranged
from 5 to 30 years. The patients were confined to
the hospital during the study period, but were
ambulatory. Patients 4 and 11 received 0.5 mg of
aminopterin daily for 3 and 2 days, respectively,
before the study began. For a period of at least 3
months before hospitalization none of the other
patients received any oral therapy for the psoriasis.
Seven normal non-psoriatie subjects, 5 females
and 2 males, ranging in age from 21 to 44 years
were used to obtain control values for urinary
amino acid content (9).
Plan of study. Each subject underwent a
thorough physical examination in addition to
clinical laboratory tests which included liver and
renal function studies. Liver function studies in-
cluded serum bilirubin, total serum protein and
albumin to globulin ratio, cephalin-floeculation
test and alkaline phosphatase determination.
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Renal function was evaluated by means of blood
urea nitrogen determination and routine urinalysis.
Twenty-four hour urine collections were made
using phenol as a preservative; volume was
measured; specific gravity determined, and an
aliquot frozen for amino acid analysis. Blood was
withdrawn while the patient was in a fasting state;
plasma was separated by centrifugation.
Chemical methods. Urine was prepared for
amino acid analysis by the method of Stein (10).
Plasma was prepared for analysis by the method of
Stein and Moore (11). Amino acids and other nm-
hydrin-reacting substances in the samples were
determined by the quantitative ion-exchange
ehromatographie method of Spaekman, Stein and
Moore (12). Unknown peaks 1, 2, and 3 in Table I
refer to compounds eluted in the same ehromato-
graphic positions as phosphoserine plus eysteia
acid, phosphoethanolamine, and earnosine from
standard amino acid solutions (Spaekman et al
(12) and this laboratory).
RESULTS
Urinary free amino acids. In Table I are listed
the content of 33 amino acids and other
ninhydrin-reacting substances in the urine of 13
subjects with psoriasis. The range and average
values of these substances for 7 control subjects
are included. In general, the urinary amino
acid values for psoriatie subjects were within or
close to the ranges of values for control subjects
except for unknown peak 1, ethanolamine, and
sarcosine (N-methylated glycine). The last was
the most notable exception; urine from S of the
psoriatic subjects (no. 1, 5, 6, 7, 10, 11, 12, 13)
contained from 8.8 to 46.5 mg with an average
of 26.7 mg per 24 hours compared to the control
range of 0 to 4.9 mg.
When values for the 13 psoriatie patients were
averaged, 1-methyl histidine, asparagine plus
glutamine, glycine, taurine, and histidine, in
decreasing order, occurred in the largest amounts
in urine. Glycine, histidine, asparagine plus
glutamine, taurine, and unknown peak 3 were
most abundant in urine from control subjects
(Table I).
Although the amount of 1-methylhistidine in
urine of individuals with psoriasis was within the
control range, except for subjects 4, 5, 9, and 10,
the ratio of 1-methylhistidine to histidine in the
N
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TABLE II
Ratio of the amounts of urinary 1-methylhistidine
and 3-methylhistidine to histidine in psoriatic
and control subjects
.Subject Sex Age 1-Methyihistidine. . .ilistidsue
3-Methyihistidine
.Histidine
Psoriatic
2*
4*
5
9
10
11
12
1
3
6
7
8
13
F
F
F
M
M
M
M
F
F
M
M
M
M
26
58
64
41
46
48
52
21
31
13
20
34
65
10.7
8.6
3.5
1.4
4.4
3.0
1.1
1.4
3.1
0.3
0.9
0.3
0.1
0.3
0.7
2.4
2.1
0.5
0.4
0.8
1.2
0.4
1.4
2.6
0.8
0.7
1.0
0.5
0.4
0.6
Controlt
14
15
16
17
18
19
20
F
F
F
F
F
M
M
21
22
24
24
44
29
30
1.0
0.1
0.6
0.3
0.3
0.1
0.2
0.3
0.3
0.3
0.4
0.5
0.2
0.3
* Two, consecutive, 24 hour urine collections
were made on subjects 2 and 4.
f Hubbard (9).
urine of 7 of the 13 subjects with psoriasis
exceeded that of the control subjects (Table II).
In subjects 2, 4, 5, 9, 10, 11, and 12 this ratio
ranged from 1.1 to 10.7 with an average of 4.1
as compared to a range of 0.1 to 1.0 with an
average of 0.4 in the control subjects. In the
other 6 psoriatie subjects the ratios were within
the control range.
In 9 of the subjects with psoriasis the ratio of
3-methyihistidine to histidine was higher than
that for control subjects. In subjects 1, 2, 3, 5,
6, 9, 11, 12, and 13 this ratio ranged from 0.6 to
2.6 with an average of 1.4, as compared to a
range of 0.2 to 0.5 with an average of 0.3 in the
control subjects (Table II). In the other 4
psoriatics the ratios were within the control
range.
Plasma amino acid content. In Table III are
listed 26 amino acids and other ninhydrin-
reacting compounds in the plasma of 6 psoriatics
with values for non-psoriatic control subjects
reported by other workers (11, 13, 14). Except
for isolated values, the amino acids and their
derivatives in plasma from psoriatie subjects
were within the control ranges.
DISCUSSION
From the data presented it would seem that in
general the pattern of amino acids and other
ninhydrin-reaeting substances in urine and
plasma is the same in individuals with psoriasis
as in non-psoriatic controls.
Patients with psoriasis, however, do have an
abnormal pattern of methylated derivatives of
free glycine and histidine in the urine. In the
case of N-methylated glycine (sarcosine) the
amount excreted was higher than normal; in the
case of 1-methyl and 3-methylhistidine the
absolute amount was not usually higher than
normal, hut when compared to the amount of
histidine excreted, the ratio was abnormally
high. The increased ratios of 1-methylhistidine to
histidine, 3-methylhistidine to histidine, and the
increased excretion of N-methyl glyeine did not
necessarily parallel each other in the psoriatie
patients. Three of the patients, however, did
show all 3 abnormalities, and 9 showed at least
2 of the abnormalities. Twelve of the patients
showed at least one of the deviations.
That the abnormal urinary 1-methylhistidine
to histidine ratio showed by some of the psoriatic
patients was not limited to a single 24 hour period
is illustrated by patients 2 and 4 who had the
increased ratio in 2 consecutive 24 hour urine
samples.
Several of the psoriatie subjects in the study
who showed abnormally increased ratios of 1-
methylhistidine to histidine, had amounts of
free histidine below control range in the urine.
Normally histidine is excreted in the main as the
free amino acid and acid hydrolysis of the urine
liberates only small amounts that exist in conju-
gated forms (10). If the psoriatie patient, how-
ever, excreted the amino acid mainly in conju-
gated form, this might account for the abnormally
high ratios of 1-methylhistidine to histidine, and
3-methylhistidine to histidine found in the study.
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TABLE III
Amino acid conen1 of plasma in psorias'is (mq per 100 ml)
No
Age
Sex
Psoriatic Subjects Control Range
3
31
F
5
64
F
7
20
M
9
41
M
10
46
M
13
65
M
std '° *an oore Soupartt CudSwDorthan en
Amino acids
Taurine 0.58 O.S2 0.48 0.62 — 0.55 0.41—0.82 0.85—1.23 0.79—1.3
Hydroxyproline 0.07 0 0.23 0.30 0.16 0
Aspartic acid 0.18 0.03 0.01 0.02 0.04 0.04 0.03—0.07 0.02—0.07 0—0.09
Threonine 2.80 1.12 1.27 1.48 1.17 1.46 1.21—1.72 1.01—1.89 1.3—2.0
Serine 1.93 1.11 0.98 — 1.28 1.31 1.01—1.25 1.07—1.43 1.2—1.4
Aspaiagine and gluta-
mine 13.68 11.28 9.35 11.17 10.71 12.47
Proline 2.72 1.90 2.09 2.65 1.55 2.44 1.84—3.34 1.17—1.99 1.7—2.6
Glutamic acid 0.80 0.81 0.30 0.70 0.45 0.66 0.43—1.15 0.38—0.79 0.56—1.3
Citrulline 0.29 0.84 0.54 0.65 0.60 0.76
Glycine 1.65 2.91 1.13 2.03 1.44 1.37 1.34—1.73 1.41—2.10 1.8—2.2
Alanine 2.80 2.82 2.10 3.04 2.11 3.03 3.01—3.73 2.13—2.99 2.3—3.6
a-Amino-n-butyric acid. — — 0.23 — 0 0.92 0.22—0.35 0.17—0.21 0.18—0.29
Valine 2.81 3.38 2.72 2.40 2.67 2.63 2.37—3.71 1.71—2.44 2.3—3.3
Cystine 1.40 2.08 0 1.46 0.48 2.29 1.08—1.30 0.55—1.09 0.20—1.5
Methionine 0.36 0.26 0.34 0.28 0.28 0.39 0.33—0.43 0.09—0.35
Isoleucine 1.05 0.94 0.87 0.83 0.70 0.87 0.69—1.28 0.63—0.71 0.61—0.89
Leucine 1.95 2.04 1.91 1.77 1.73 1.82 1.42—2.30 1.08—1.27 1.2—1.7
Tyrosine 1.19 1.37 0.80 0.90 0.81 1.41 0.81—1.45 0.58—0.73 0.64—0.99
Phenylalanine 0.84 0.94 0.76 0.89 0.78 0.96 0.69—0.95 0.61—0.85 0.80—0.91
Ornithine 1.10 1.09 0.98 1.08 1.32 1.01 0.62—0.80 0.39—0.51 0.63—1.2
Ethanolamine 0.04 0.04 0.15 0.04 <0.01 0.04
Lysine 3.17 3.87 2.60 3.04 2.31 2.78 2.51—3.02 1.21—1.87 2.1—2.4
1-Methylhistidine 0.06 0.51 <0.01 0.11 0 0.06 0.04—0.17 0.05—0.29
Histidine 1.02 0.98 0.89 0.94 0.90 0.84 0.79—1.48 0.69—1.09 1.2—1.5
3-Mcthylhistidine 0.04 0.03 0.01 0.02 <0.01 <0.01 0.07—0.13 0—0.06
Arginine 0.96 1.48 1.15 1.18 0.87 1.08 1.22—1.93 0.37—0.93 1.0—2.4
* Five male subjects (11).
t Five female subjects (13).
Two female and 2 male subjects (14).
§ Result was not obtained for technical reasons.
Such was not the case though, for after acid
hydrolysis of urine from subjects 2 and 5, 1-
methyihistidine to histidine ratios were 5.3 and
3.4, respectively, as compared to 8.9 and 4.4
before hydrolysis (control range 0.1—1.0). The
3-methyihistidine to histidine ratios after acid
hydrolysis were 1.1 and 0.7 as compared to 2.1
and 08 before hydrolysis (control range 0.2—0.5).
From the results of this study it would seem
that psoriatic individuals have a metabolic
aberration that manifests itself in an unusual
methylation of at least 2 urinary amino acids,
glycine and histidine. To our knowledge this is the
first demonstration of such a metabolic abnor-
mality in psoriasis.
Other workers have reported isolated cases in
which the ratio of urinary 1-methyihistidine to
histidine was abnormally high. Soupart (13)
found a ratio of 1-methylhistidine to histidine of
1.5 in one woman in the follicular phase of the
menstrual cycle; the ratio was decreased to 0.5
during the luteal phase. Cusworth and Dent (14)
reported one patient with hyperparathyroidism,
another with argininosuccinic aciduria, and a
child with Fanconi syndrome with cystinosis who
had urinary ratios of 1-methyihistidine to
histidine of 1.1, 2.8, and 1.1, respectively. Evered
(15), however, found no 1-methylhistidine in the
urine of one child with Fanconi syndrome. This
latter worker did report two cases of osteomalacia
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with 1-methyihistidine to histidine ratios of 4.1
and 4.2. Cusworth and Dent (14), on the other
hand, reported a normal ratio (0.7) between the
two compounds in one ease of nutritional osteo-
malacia.
Brown et at (16) have shown that C-14 labeled
1-methylhistidine is excreted in the urine of
human subjects given uniformly labeled C-14
histidine orally. These workers did not determine
3-methylhistidine, so one does Dot know if this
compound would have been excreted' labeled with
C-14. Other than this study, little is known of the
metabolic origin of 1-methylhistidine, and noth-
ing is known of the metabolic origin of 3-methyl-
histidine, although both are constituents of hu-
man urine (9, 10, 17).
SUMMARY
1. Urinary and plasma amino acids and other
ninhydrin-reaeting substances were determined
in 13 patients with psoriasis by use of quantitative
ion-exchange chromatography.
2. Patients with psoriasis usually showed an
abnormal pattern of methylated derivatives of
free glycine and histidine in the urine. N-methyl-
ated glycine was excreted by S of the patients in
amounts greater than those for control subjects.
Although the absolute amounts of 1-methyl and
3-methylhistidine were not usually greater than
those for the control subjects, the ratio of 1-
methylbistidine to histidine was abnormally high
in 7 of the 13 patients; the ratio of 3-methyl-
histidine to histidine was abnormally high in 9 of
the 13 psoriatic patients.
3. In general, the pattern of amino acids and
their derivatives in urine and plasma is the same
in psoriatie as in non-psoriatie individuals.
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